Topical Finasteride vs Dutasteride: Which Is Better for Hair Loss?
Topical finasteride and topical dutasteride both target the DHT pathway involved in male pattern hair loss, but they are not the same medicine. Dutasteride inhibits a broader range of 5-alpha-reductase enzymes, while topical finasteride currently has the more established clinical evidence base.
So is topical dutasteride stronger, and does that make it better? The answer is more nuanced than simply choosing the most potent DHT blocker.
Which is better?
There is not yet enough direct topical-vs-topical evidence to declare one universal winner.
Topical finasteride has been evaluated in large Phase III studies. Topical dutasteride is newer, but a 2025 Phase II study produced encouraging results, particularly with 0.05% topical dutasteride.
Dutasteride is the broader 5-alpha-reductase inhibitor, but greater pharmacological potency does not automatically mean it is the best treatment for every person.
Topical Finasteride vs Dutasteride at a Glance
| Feature | Topical Finasteride | Topical Dutasteride |
|---|---|---|
| Drug class | 5-alpha-reductase inhibitor | 5-alpha-reductase inhibitor |
| Enzyme inhibition | Primarily type II 5-alpha-reductase | Type I and type II 5-alpha-reductase |
| Primary aim | Reduce DHT activity involved in follicle miniaturisation | Reduce DHT activity through broader 5-alpha-reductase inhibition |
| Topical evidence | Relatively mature, including large Phase III clinical trials | Emerging, including a 2025 Phase II clinical trial |
| Direct topical comparison | High-quality direct topical finasteride vs topical dutasteride evidence remains limited. | |
| Systemic absorption | Can occur | Can occur |
| Prescription required | Yes | Yes |
| Can be combined with minoxidil? | May be considered in an individual treatment plan | May be considered in an individual treatment plan |
Finasteride vs Dutasteride: The Main Biological Difference
Both medicines inhibit 5-alpha-reductase, the enzyme involved in converting testosterone into dihydrotestosterone, or DHT. The important difference is the range of enzyme isoforms they inhibit.
More selective inhibition
Finasteride primarily inhibits type II 5-alpha-reductase. This reduces DHT and targets an important mechanism involved in androgenetic alopecia.
Broader inhibition
Dutasteride inhibits both type I and type II 5-alpha-reductase. This broader inhibition is one reason dutasteride can produce greater DHT suppression when used systemically.
More DHT inhibition does not automatically mean a better topical treatment
The amount of medicine reaching the scalp, systemic absorption, formulation, concentration, application volume, tolerability and strength of clinical evidence all matter. Pharmacological potency is only one part of the treatment decision.
What Does the Evidence Say About Topical Finasteride?
Topical finasteride has a considerably more developed clinical evidence base than it did several years ago.
European Phase III trial
A 24-week randomised Phase III study in men with androgenetic alopecia found topical finasteride produced a significantly greater increase in target-area hair count than placebo. The improvement was numerically similar to oral finasteride.
The study also found markedly lower plasma finasteride exposure with the topical formulation and a smaller mean reduction in serum DHT than with oral finasteride.
View study on PubMedAdditional Phase III evidence
A further multicentre Phase III trial in Chinese men with androgenetic alopecia also found topical finasteride significantly improved target-area hair count versus placebo at 24 weeks and was generally well tolerated.
View study on PubMedWhat Does the Evidence Say About Topical Dutasteride?
Topical dutasteride has historically had a much smaller evidence base than topical finasteride. That changed meaningfully with publication of a randomised Phase II trial in 2025.
2025 Phase II topical dutasteride trial
The study randomised men with androgenetic alopecia to topical dutasteride 0.01%, 0.02% or 0.05%, oral finasteride 1 mg, or placebo for 24 weeks.
Topical dutasteride showed a dose-dependent improvement in target-area hair count and hair width compared with placebo. The 0.05% topical dutasteride group also showed a statistically significant improvement in target-area hair count compared with the oral finasteride 1 mg group at week 24.
The study reported modest serum testosterone and DHT changes in the dutasteride groups and no irritation in the active treatment groups.
View study on PubMedImportant: this does not prove topical dutasteride beats topical finasteride
The active comparator in this study was oral finasteride 1 mg, not topical finasteride. It would therefore be incorrect to use this trial to claim that topical dutasteride 0.05% has been proven superior to topical finasteride.
Larger and longer-term trials, particularly direct topical-vs-topical comparisons, would strengthen the evidence considerably.
Is Dutasteride More Effective Than Finasteride?
When the medicines are used orally, there is evidence that dutasteride can produce greater improvements in hair-growth outcomes than finasteride in men with androgenetic alopecia.
A systematic review and meta-analysis comparing oral dutasteride with oral finasteride found dutasteride produced greater improvements across several hair-growth measures during the studied period.
But oral evidence cannot simply be transferred to topical treatment
Different topical formulations produce different delivered doses, scalp exposure and systemic exposure. Evidence that oral dutasteride can outperform oral finasteride therefore supports the biological rationale for dutasteride, but it does not establish that every topical dutasteride formulation will outperform topical finasteride.
Topical Finasteride or Dutasteride: Which Should You Choose?
Rather than declaring one treatment universally better, the decision can be viewed through three different questions.
Who Might Explore Topical Finasteride?
Evidence-led starting point
Someone who values the larger existing topical clinical evidence base may prefer to discuss finasteride first.
Lower-dose strategy
Topical finasteride has also been studied across different concentrations, including very low-strength formulations.
Low Dose Topical FinasterideOral vs topical decision
People already considering finasteride may want to compare topical treatment with the conventional oral route.
Topical vs Oral FinasterideWho Might Explore Topical Dutasteride?
Broader DHT inhibition
Someone specifically interested in dual type I and type II 5-alpha-reductase inhibition may want to discuss dutasteride.
Alternative DHT-focused route
Dutasteride may be explored as an alternative DHT-focused strategy where clinically appropriate.
Emerging topical evidence
The newer Phase II topical evidence makes dutasteride an increasingly relevant option to discuss, while recognising that its topical evidence base remains less mature.
Topical Dutasteride GuideCan Topical Finasteride or Dutasteride Be Combined With Minoxidil?
Finasteride and dutasteride are DHT-focused treatments, while minoxidil works through a different hair-growth pathway. This creates a rationale for considering a DHT-focused medicine alongside minoxidil in selected treatment plans.
That does not mean every patient needs multiple active ingredients. The appropriate formulation should reflect diagnosis, previous treatment, tolerability, medical history and clinical assessment.
Finasteride + Minoxidil
Explore the evidence and rationale behind combining topical finasteride with minoxidil.
Explore Finasteride + MinoxidilPersonalised formulation
Explore different topical ingredients and strengths through a personalised pathway.
Hair CustomiserTopical Finasteride vs Dutasteride Side Effects
Both medicines belong to the 5-alpha-reductase inhibitor class. Using them topically does not mean systemic absorption or systemic adverse effects are impossible.
Current UK safety position
The MHRA states that finasteride is associated with depression, suicidal ideation and sexual dysfunction, and that sexual dysfunction may persist after stopping treatment.
Relevant psychiatric history and potential adverse effects should therefore be considered when prescribing.
Finasteride Side EffectsCurrent UK safety position
The MHRA’s 2026 review did not establish the same causal association between dutasteride and suicidal ideation. However, because dutasteride works in a similar way to finasteride, precautionary information about potential mood alterations is being added to dutasteride product information.
Sexual dysfunction also remains an important adverse-effect consideration with dutasteride.
Topical treatment still requires clinical assessment
Neither topical finasteride nor topical dutasteride should be marketed as having “no systemic side effects”. Exposure depends on the medicine, concentration, delivered dose, vehicle, application pattern and individual patient factors.
Topical Finasteride vs Dutasteride: The Verdict
If you prioritise the maturity of the topical evidence: topical finasteride currently has the stronger position.
If you prioritise broader 5-alpha-reductase inhibition: dutasteride has the pharmacological advantage because it inhibits both type I and type II enzymes.
If you are asking which topical medicine has been proven more effective head-to-head: the evidence is not yet strong enough to declare a definitive winner.
The 2025 topical dutasteride trial is encouraging and makes topical dutasteride an important emerging option, but more direct comparative and longer-term research is needed.
Explore Related Hair Loss Guides
Finasteride or Dutasteride? Explore Your Topical Options
Use the Root & Radiance Hair Customiser to explore personalised topical hair-loss formulations and strengths. Selecting an ingredient does not guarantee that it will be prescribed. Prescription-only treatment remains subject to clinical assessment and prescriber approval.
Topical Finasteride vs Dutasteride FAQs
Is topical dutasteride stronger than topical finasteride?
Dutasteride inhibits both type I and type II 5-alpha-reductase, while finasteride primarily inhibits type II. This makes dutasteride a broader 5-alpha-reductase inhibitor, but it does not automatically prove that every topical dutasteride formulation is clinically superior to topical finasteride.
Which is better for hair loss, topical finasteride or dutasteride?
There is currently insufficient direct topical-vs-topical evidence to declare one universally better. Topical finasteride has the more mature clinical evidence base, while topical dutasteride has promising newer Phase II evidence.
Does dutasteride block more DHT than finasteride?
Dutasteride inhibits both type I and type II 5-alpha-reductase, whereas finasteride primarily inhibits type II. Systemically, dutasteride therefore produces broader inhibition of DHT formation.
Has topical dutasteride been clinically studied?
Yes. A 2025 Phase II study evaluated topical dutasteride 0.01%, 0.02% and 0.05% in 135 men with androgenetic alopecia over 24 weeks.
Did topical dutasteride outperform finasteride?
In the 2025 Phase II trial, topical dutasteride 0.05% significantly improved target-area hair count compared with oral finasteride 1 mg at week 24. The comparator was oral finasteride, not topical finasteride, so the study does not prove superiority over topical finasteride.
Does topical finasteride work?
Topical finasteride has been evaluated in Phase III clinical trials. A large European trial found significantly greater improvement in target-area hair count than placebo at 24 weeks.
Which has more evidence, topical finasteride or topical dutasteride?
Topical finasteride currently has the more mature evidence base, including large Phase III clinical trials. The topical dutasteride evidence is newer and less extensive.
Can topical finasteride and dutasteride cause systemic side effects?
Systemic exposure can occur with topical medicines. The extent depends on the formulation, concentration, delivered dose, application and individual factors. Topical administration should not be interpreted as guaranteeing an absence of systemic adverse effects.
Can finasteride or dutasteride be combined with minoxidil?
A DHT-focused treatment may be considered alongside minoxidil because the medicines act through different pathways. Whether combination treatment is appropriate requires individual clinical assessment.
Can I get personalised topical finasteride or dutasteride in the UK?
Root & Radiance provides a Hair Customiser where personalised topical hair-loss options can be explored. Prescription-only treatment is supplied only where clinically appropriate following prescriber review.
Evidence and Further Reading
- Piraccini BM et al. Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia: a phase III, randomized, controlled clinical trial. PubMed
- Zhou C et al. Efficacy and safety of topical finasteride spray solution in the treatment of Chinese men with androgenetic alopecia: a phase III, multicenter, randomized, double-blind, placebo-controlled study. PubMed
- Panuganti VK et al. A Randomized, Double-Blind, Placebo and Active Controlled Phase II Study to Evaluate Novel Dutasteride Topical Solution in Male Subjects With Androgenetic Alopecia. PubMed
- Zhou Z et al. The efficacy and safety of dutasteride compared with finasteride in treating men with androgenetic alopecia: a systematic review and meta-analysis. PubMed
- Medicines and Healthcare products Regulatory Agency. Finasteride and Dutasteride: updated safety warnings for psychiatric side effects and sexual dysfunction. MHRA